At a glance
ClinicalIndex Comparison Record- ✓Diagnosis of anorexia nervosa
- ✓Age over 18 years
- ✓Female sex
- ✓Documented decreased bone density
- ✕Current use of medications to increase bone density
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
IGF-1 and Bone Loss in Women Anorexia Nervosa
In Brief
A Phase 3 clinical trial evaluating Testosterone, Actonel (risedronate), and 2 other interventions for Anorexia Nervosa. Completed, enrolled 77 participants across 1 site.
Detailed Summary
Women with Anorexia Nervosa have been found to have low bone density. The study will determine whether administration of low doses of a natural hormone, testosterone and/or risedronate, a medication to help prevent bone breakdown will improve or prevent bone loss in this condition.
Study Details
Timeline
Interventions
Testosterone patch 150mcg daily
Actonel (risedronate) 35mg PO one time weekly
Placebo tablet identical in appearance to active Actonel (risedronate) tablet
Placebo patch identical in appearance to testosterone patch